Bastide le Confort Medical (FR:BLC) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Groupe Bastide reported a strong financial performance for the 2023-2024 fiscal year, with revenue climbing to €529.8 million and an 8.5% recurring operating margin that surpassed the company’s target. The growth was driven by significant market gains in the Respiratory and Diabetes sectors, as well as a return to growth in Homecare equipment sales. Looking ahead, the company focuses on improving profitability and reducing debt.
For further insights into FR:BLC stock, check out TipRanks’ Stock Analysis page.